Osaic Holdings
SGMO

Osaic Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Osaic Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.73K Sell
6,980
-150
-2% -$60 ﹤0.01% 7089
2025
Q4 		$2.99K Sell
7,130
-1,000
-12% -$530 ﹤0.01% 6944
2025
Q3 		$4.92K Buy
8,130
+1,000
+14% +$539 ﹤0.01% 6750
2025
Q2 		$3.85K Buy
7,130
+3,170
+80% +$1.88K ﹤0.01% 6687
2025
Q1 		$2.61K Sell
3,960
-2,670
-40% -$2.83K ﹤0.01% 6490
2024
Q4 		$6.76K Buy
6,630
+910
+16% +$1.66K ﹤0.01% 6029
2024
Q3 		$4.96K Sell
5,720
-200
-3% -$147 ﹤0.01% 6201
2024
Q2 		$2.13K Sell
5,920
-3,630
-38% -$1.96K ﹤0.01% 6579
2024
Q1 		$6.4K Sell
9,550
-394
-4% -$286 ﹤0.01% 5976
2023
Q4 		$5.4K Sell
9,944
-2,566
-21% -$1.18K ﹤0.01% 6136
2023
Q3 		$7.5K Sell
12,510
-4,190
-25% -$4.49K ﹤0.01% 6088
2023
Q2 		$22.1K Sell
16,700
-2,523
-13% -$3.45K ﹤0.01% 5498
2023
Q1 		$32.8K Buy
19,223
+331
+2% +$945 ﹤0.01% 5256
2022
Q4 		$60.4K Sell
18,892
-2,458
-12% -$9.54K ﹤0.01% 4793
2022
Q3 		$105K Hold
21,350
– – ﹤0.01% 4327
2022
Q2 		$89K Sell
21,350
-2,547
-11% -$11K ﹤0.01% 4519
2022
Q1 		$192K Buy
23,897
+2,684
+13% +$16K ﹤0.01% 4067
2021
Q4 		$160K Sell
21,213
-763
-3% -$6.63K ﹤0.01% 4163
2021
Q3 		$199K Buy
21,976
+1,664
+8% +$16.4K ﹤0.01% 3906
2021
Q2 		$244K Sell
20,312
-7,880
-28% -$89.2K ﹤0.01% 3701
2021
Q1 		$353K Buy
28,192
+11,572
+70% +$156K ﹤0.01% 3235
2020
Q4 		$257K Sell
16,620
-885
-5% -$10.4K ﹤0.01% 3246
2020
Q3 		$166K Sell
17,505
-322
-2% -$3.48K ﹤0.01% 3408
2020
Q2 		$161K Sell
17,827
-807
-4% -$7.49K ﹤0.01% 3330
2020
Q1 		$119K Buy
+18,634
New +$138K ﹤0.01% 3331

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Osaic Holdings's SGMO Position: Q1 2026 in Review

Osaic Holdings reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 2.1% in Q1 2026, selling an estimated $60 and leaving 6,980 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #7089.

Osaic Holdings first reported a position in SGMO in Q1 2020 and has held it in 25 quarters since. The position peaked at $353K in Q1 2021. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Osaic Holdings held 6,980 shares of SANGAMO THERAPEUTICS INC worth $1.73K as of Q1 2026.
  • Osaic Holdings sold 150 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $60.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7089 holding.
  • Osaic Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's SANGAMO THERAPEUTICS INC position peaked at $353K in Q1 2021.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.